Research Article Neuroprotective Effect of Polyherbal Recipe Containing Ginger, Chinese Date, and Wood Ear Mushroom against IschemicStroke with Metabolic Syndrome Condition via EpigeneticModification of Inflammation and Oxidative Stress Thuntiva Nakyam ,1Jintanaporn Wattanathorn ,2,3and Wipawee Thukham-mee2,3 1Department of Physiology and Graduate School (Neuroscience Program), Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand 40002 2Research Institute for Human High Performance and Health Promotion, Khon Kaen University, Khon Kaen, Thailand 40002 3Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand 40002 Correspondence should be addressed to Jintanaporn Wattanathorn; jinwat05@gmail.com Received 12 May 2022; Revised 20 June 2022; Accepted 21 July 2022; Published 17 August 2022Academic Editor: Luca Fiorillo Copy right ¬© 2022 Thuntiva Nakyam et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Currently, the prevalence of stroke with metabolic syndrome (MetS) is increasing and the current therapeutic eÔ¨É ciency is still limited. Therefore, the applications of herbal recipes have gained much attention.The polyherbal recipe containing ginger, Chinese date, and wood ear mushroom is reputed for atherosclerosis and stroke prevention.It has been long-term consumed without scienti Ô¨Åc support.Therefore, this study was carried out to determine the neuroprotective eÔ¨Ä ect and its mechanisms in animal model of ischemic stroke with MetS.Male Wistar rats weighing 180-220 g were exposed to a 16-week high-fat high- carbohydrate feeding.The rats with the MetS characteristic were exposed to a temporary occlusion of the right middle cerebralartery (MCAO) for 90 minutes.
They were orally fed with the polyherbal recipe (GCJ) at the doses of 100, 200, and 300 mg/kgBW for 21 days and assessed the neurological de Ô¨Åcit, ion volume, cortical neuron density in the cerebral cortex, oxidative stress status, in Ô¨Çammation, and expressions of histone deacetylase 3 (HDAC3) and DNA methyltransferase 1 (DNMT1). The results showed that GCJ signiÔ¨Å cantly improved all mentioned parameters.Therefore, GCJ is the potential neuroprotectant against ischemic stroke with MetS.The underlying mechanisms may involve the reduction of oxidative stress, in Ô¨Çammation, and the modi Ô¨Åcation of epigenetic mechanism via the reduction of HDAC3 and DNMT1.However, further clinical investigation is essential to con Ô¨Årm this positive modulation eÔ¨Ä ect.1.Introduction Metabolic syndrome (Mets), a cluster of conditions including hypertension, diabetes, atherogenic dyslipidemia, and centralobesity, is recognized as an important risk factor for strokedevelopment [1, 2].
MetS disturbs cerebral microvascular blood Ô¨Çow giving rise to the reduction of cerebral blood Ô¨Çow and Ô¨Ånally exposing the brain tissue to a higher state of hypoxia [3]. In addition, the elevatio no fp r o o x i d a t i v ea n dp r o i n Ô¨Çamma- tory states induced by MetS also contributes an important role on the development of atheroscler o t i cp l a q u ea n dt h r o m b o s i s -embolic stroke [4].Therefore, the prevalence of stroke withMetS appears to increase in accompany with the increasingtrend of MetS [5].It has been reported that stroke with MetSshows poor prognosis.In additi on, stroke survivors with MetS also show the higher mortality rate and stroke recurrence thanthose without MetS [6].Since stroke produces a great socioeco-nomic burden and the current th erapeutic strategy is still limited, it is very esse ntial to prevent it [7].At present, the application of herbal products for stroke prevention has gained much attention.
Although the herbal products in the market are present both in single herbHindawi BioMed Research International Volume 2022, Article ID 8940303, 14 pages https://doi.org/10.1155/2022/8940303 formulation and in polyherbal formulation, the concept of polyherbalism has gained much attention because the activephytochemical constituents presented in each individualplant usually exist in a small amount and do not achievetherapeutic levels. The combination of herbs often providesgreater bene Ô¨Åts due to the synergistic interaction.One possi- ble explanation for the positive modulation e Ô¨Äect induced by synergistic e Ô¨Äect is the capacity to exert the e Ô¨Äect at multiple targets simultaneously which is suitable for the complex dis- orders which involve multiple factors.In addition, most polyherbal formulation often provides the desirable e Ô¨Äect with lower dose than the single formulation [8].
In Thailand,the polyherbal drink containing ginger ( Zingiber o Ô¨Écinale Roscoe), Chinese date ( Ziziphus jujuba Mill.), and wood ear mushroom or Jew ‚Äôs ear mushroom ( Auricularia auric- ula-judae ) has been consumed by the Thai-Chinese descents in the northern part of Thailand based on the belief that thispolyherbal drink can improve blood cholesterol and athero-sclerosis. Due to the crucial role of atherosclerosis on thepathophysiology of stroke [2], the polyherbal drink men-tioned earlier is also used for preventing ischemic stroke.However, no scientiÔ¨Å c evidence concerning this e Ô¨Äect is available.Therefore, this study was set up to determine the eÔ¨Äect of this polyherbal recipe and to explore its underlying mechanisms in animal model of metabolic syndrome withischemic stroke.2.Materials and Methods 2.1.Preparation of the Polyherbal Recipe (GCJ).Ginger, Chi- nese date, and wood ear mushroom were harvested fromOctober 2020 to January 2021.
The ginger ( Zingiber o Ô¨Éci- nale Roscoe) was authenticated by the KKU herbarium (KKU-NO. 25652), and Chinese date ( Ziziphus jujube Mill.) was identi Ô¨Åed by KKU herbarium (KKU-NO.25654).The voucher specimens ginger and Chinese datewere authenticated by Assistant Professor Pimwadee Porn-pongrungrueng, the plant taxonomy expert from the Fac-ulty of Science, Khon Kaen University.The wood ear orthe Jew ‚Äôs ear mushroom ( Auricularia auricula-judae Bull.) utilized for this study was sourced from Mahasarakhamprovince, International Herbarium Index (MSUT-7282).Voucher specimens were authenticated by Assistant Pro-fessor Khwanruan Naksuwankul and deposited at High Human Performance and Health Promotion Research Institute (HHP&HP), Khon Kaen University, Thailand.For the extract preparation, ginger, Chinese date, andwood ear mushroom were washed, dried in the oven (72hours at 60 ¬∞C), and grounded as powder.
Both ginger and wood ear mushroom were prepared as water extractby using a decoction technique whereas a water extractof Chinese date was prepared using maceration technique.All extracts were centrifuged at 3000 rpm for 10 minutes.Following this process, the solution was harvested and Ô¨Ål- trated with Whatman paper. Then, they were dried with a freeze dryer.The polyherbal recipe was prepared by com- bining all extracts at a ratio of 1 : 1 : 1 owing to the highestpotential in biological activities associated with the patho-physiology of metabolic syndrome and ischemic stroke.2.2.Experimental Protocol.All animals used in this study were male Wistar rats weighing 180-220 g from Nomura SiamInternational Co., Ltd., Thailand.They were housed in stan-dard metal cages (6 animals per cage), under the standard con-dition with 23 ¬± 2 ¬∞C, 12 : 12 hours of the light-dark cycle, and were allowed free access to water and food throughout thestudy.
All animals were subjected to a one-week acclimatiza-tion period. All procedures in this study were approved bythe Institutional Animal Ethics Committee (report no.IACUC-KKU 42/63).After acclimatization, all rats were randomly divided into 8g r o u p s( N=6/group).Rats in group I (ND+vehicle) were treated with a normal diet (4.5% fat, 44.8% carbohydrate, 24% protein, and 5% Ô¨Åber) whereas rats in group II-group VIII were fed with high-carbohydrate high-fat diet (HCHF)(19.36% fat, 52.94% carbohydrate, 22.2% protein, and 3.28%Ô¨Åber) in order to induce metabolic syndrome and this rat model can produce the physiological changes and manifesta-tion mimic metabolic syndrome in human better than othermodels [9, 10].
To mimic the real situation in MetS, only ratsthat showed the characteristic similar to those presented in the human metabolic syndrome condition such as obesity (the body weight gain more than 40% [11]), hyperglycemia (theplasma glucose more than 100 mg/dL [12]), and hypertension(systolic and diastolic pressure more than 130 and 85 mmHg[13]) were recruited for further study. Rats in group II(HCHF+sham+vehicle) were exposed to sham operationwhile rats in group III-group VIII were exposed to a tempo-rary occlusion of the right middle cerebral artery (MCAO)via a 90-minute reperfusion injury.Group II was designed toobserve the e Ô¨Äect of sham operation and vehicle on the inter- ested brain parameters.After MCAO, rats in group III (HCHF+MCAO+vehicle), group IV (HCHF+MCAO+vitamin C), and group V (HCHF+MCAO+piracetam) were fed with vehi- cle, vitamin C (250 mg/kg BW), and piracetam (250 mg/kgBW), respectively.
Group III was designed to observe the e Ô¨Äect of MCAO which mimicked brain injury, and brain dysfunc-tion presented in ischemic stroke because vehicle is waterand produced no e Ô¨Äect on the parameters just mentioned. Both group IV and group V were served as the positive controlgroup because both vitamin C (a well-known antioxidant) andpiracetam (a standard drug used for treating stroke in order toimprove cerebral blood Ô¨Çow and neuroin Ô¨Çammation) showed the positive modulation e Ô¨Äects on the observed parameters and they were included for comparing the observed e Ô¨Äects with the experimental group.In groups VI-VIII (HCHF+MCAO+GCJ), all MetS rats were fed with GCJ at the dosesof 100, 200, and 300 mg/kg BW, respectively.These groupswere experimental groups.
The administrations of theassigned substances were performed continually for 21 days.The assessment of severity of neurological de Ô¨Åcit was carried out by using modi Ô¨Åed neurological severity scores (mNSS) every 7 days throughout the study period. The determinationof brain infarction volume, brain edema, brain oxidative stressmarkers including malondialdehyde (MDA) level, and theactivities of catalase (CAT), glutathione peroxidase (GPx), and superoxide dismutase (SOD) together with the assessment of inÔ¨Çammatory markers such as tumor necrosis factor-alpha (TNF- Œ±) and interleukin-6 (IL-6) was also performed.In2 BioMed Research International addition, the modi Ô¨Åcation of epigenetic mechanism was also evaluated via the changes in histone deacetylase 3 (HDAC3) and DNA methyltransferase 1 (DNMT1) expressions.Allexperimental protocols are shown in Figure 1.2.3.Ischemia-Reperfusion (I/R) Injury.
After an anesthetiza- tion with pentobarbital sodium (60 mg/kg BW), a midline incision of the neck was performed. Following this step, asilicon-coated nylon was inserted into the right common carotid artery lumen and passed through the internal carotid artery until the middle cerebral artery was occluded.Theocclusion was performed for 90 minutes, and the nylon wasremoved to induce reperfusion injury.Sham-operated ratswere subjected to the same processes except that no occlusionof a middle cerebral artery was performed.After the operation,the wound was sutured, and an animal was transferred to thecage after recovering from an anesthetization [14 ‚Äì16].2.4.The Modi Ô¨Åed Method of Neurological Severity Score (mNSS) Assessment.The neurological de Ô¨Åcits comprising motor, sensory, re Ô¨Çex, and balance were monitored by using the modi Ô¨Åed method of neurological severity scores (mNSS).
The neurological de Ô¨Åcit score was graded by the trained and experienced observers who were blind to the treatment groupsof the animals. The scores were in the range between 0 and 18.The mild injury represented the score between 1 and 6whereas moderate injury represented the score between 7and 12 and the scores in the range between 13 and 18 indi-cated severe injury [17, 18].2.5.Assessment of Brain Infarction Volume.An assessment was performed 24 hours after MCAO due to the optimum change of brain infarction induced by MCAO during this period [19].Brain was isolated and cut as a coronal sectionat 2 mm thickness.Each section was immersed in 2.0% 2,3,5-TTC (Sigma, St.Louis, MO, USA) for 30 min at 37 ¬∞C (15 min with each surface facing up).All slices were washedtwice in saline, Ô¨Åxed in 10% bu Ô¨Äered formalin (pH 7.4), and left to stand at 4 ¬∞C overnight in a lightproof container [15, 16].2.6.Brain Water Content Assessment.
The brain tissue collec- tion was performed at 24 hours after a reperfusion injury. Anassessment was carried out by weighing the brain wet weight and then subsequently allowed to dry at 100 ¬∞C for 24 hours.Following this step, it was measured as brain dry weight.The Ô¨Ånal brain water content was calculated using [14] Water content =wet weight ‚àídry weight √∞√û wet weight√ó1 0 0 %: √∞1√û 2.7.Cresyl Violet Staining.The isolated brains were Ô¨Åxed with 4% of paraformaldehyde (Sigma-Aldrich, USA) (pH 7.4) at4 ¬∞C and cryoprotected by immersing in a 30% formalin- sucrose (Merck, Germany) solution for 2-3 days.Then, theywere prepared as a coronal section at 10 Œºm thick by using cryostat (Thermo Scienti Ô¨Åc‚Ñ¢HM 525 Cryostat).All sections were placed on slides coated with 0.3 percent gelatin bu Ô¨Äer containing 0.05% aluminium potassium sulfate (Sigma-Aldrich, USA).
Prior to the cresyl violet staining process, allslides were air dried and rehydrated in graded concentrationsof ethanol and xylene, respectively. Then, they were incubatedin 0.2% of cresyl violet (Sigma-Aldrich, USA) for 20 minutesaccordingly [20, 21], decolorized in acetic acid, dehydrated,and cover slipped with Permount.The evaluation of neuronaldensity in the sensorimotor cortex (bregma 1.6 to -3.0, ante-rior to posterior) was performed by using an Olympus lightmicroscope type BH-2 (Japan) at 40x magni Ô¨Åcation.The anal- ysis was performed speci Ô¨Åcally focused on neuropil, neuronal size, and shape [22].The density of the survival neurons was expressed as the number of neurons per 255 Œºm 2[22].2.8.Oxidative Stress Marker Assessment 2.8.1.Lipid Peroxidation Assessment.Level of malondialde- hyde (MDA) in the cerebral cortex was monitored by using thiobarbituric acid reactive substances (TBARSs) method[23].
Brie Ô¨Çy, 50 ŒºL of tissue homogenate, 50 ŒºL sodium dodecyl sulfate solution (SDS; Sigma-Aldrich, USA),375ŒºL 20% acetic acid solution, 375 ŒºL of 0.8% of thiobarbi- turic acid (TBA) (Sigma-Aldrich, USA), and 150 ŒºL of dis- tilled water (DW) were mixed and heated in 95 ¬∞C for 1 hour. After the samples were cooled, 250 ŒºL of distilled water and 1250 ŒºL of mixture of n-butanol : pyridine (15 :1v/v; Merck, Germany) were added and centrifuged for 10 minutes at 4000 rpm to extract the TBARS (pink com-plex color).Butanolic phase was collected and measured anabsorbance at 532 nm.The brain level of MDA was calcu-lated by using a 1,3,3-tetramethoxy propane (Sigma-Aldrich108383-100ML) standard curve at the concentration rangebetween 0 and 15 ŒºM.The measurement was performed in triplicate, and results were expressed as ng/mg protein.2.8.2.Assessment of Antioxidant Enzymes.
Superoxide dis- mutase activity (SOD) was monitored via the presence of superoxide free radical generated by the cytochrome Creduction [24]. In brief, 200 ŒºL of the reaction mixture com- prising 57 mM of phosphate buÔ¨Ä er solution (KH 2PO4), 0.1 mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, USA), 50 ŒºM of xanthine solution, and 10 mM of cytochrome C solution (Sigma-Aldrich, USA) was mixedwith 20 ŒºL of samples or 1 to 25 units/mL of superoxide dis- mutase enzyme standard (Sigma-Aldrich, USA).An absor-bance was assessed at a wavelength of 415 nm.The unit ofmeasurement in SOD activity was expressed as SOD activity per mg protein.Catalase (CAT) activity was determined following the method of Palachai et al.[25].The assay mixture consisting of 50 ŒºLo f3 0 m Mo fH 2O2in 50 mM phosphate buÔ¨Ä er, pH 7.0, 150 ŒºL of 5 mM KMnO4, and 25 ŒºLo fH2SO4(Sigma- Aldrich, USA) was mixed with 10 ŒºL of brain homogenate and determined an absorbance at 490 nm by using a micro-plate reader.
An enzymatic assessment was performed intriplicate, and results were expressed as units of CAT activityper milligram of protein (U/mg protein). The determination in glutathione peroxidase (GPx) activity was performed by adding 20 ŒºL of tissue sample to the reaction mixture containing 10 ŒºL of 1 mM dithiothreitol (DTT) in 6.67 mM potassium phosphate buÔ¨Ä er (pH 7), 100ŒºL of 1 mM sodium azide (Sigma-Aldrich, USA), 10 ŒºL3 BioMed Research International of 50 mM glutathione solution, and 100 ŒºL of 30% H2O2 (BDH Chemicals Ltd., UK).Subsequently, 10 ŒºLo f1 0 m M DTNB (5,5-dithiobis-2-nitrobenzoic acid) (Sigma-Aldrich, USA) was added and incubated for 5 minutes at room tem-perature.An absorbance was assessed using a microplatereader at a wavelength of 412 nm.Results were presentedas units per mg protein [25].2.9.Western Blot Assessment.
InÔ¨Çammation and epigenetic mechanism play the crucial roles in brain damage induced by ischemic stroke [22, 26 ‚Äì28], so we also determined the eÔ¨Äect of the polyherbal recipe on these indicators. In this study, we used western blot for determining the expressionsof inÔ¨Çammatory cytokines such as interlukin-6 (IL-6) and tumor necrosis factor- Œ±(TNF- Œ±) and the expressions of both histone deacetylase 3 (HDAC3) and DNA methyltransferase1 (DNMT1) in the cerebral cortex.Brain samples of the cere- bral cortex from an ipsilateral side were homogenized with the extraction of mammalian reagent (M-PER) and the proteasecocktail inhibitor (Sigma-Aldrich, USA) at the ratio of 1 : 10for the assessment of in Ô¨Çammatory markers.
The brain sam-ples were lysed in RIPA bu Ô¨Äer or subjected to a radioimmuno- precipitation assay that incorporated 20 mM Tris-HCl pH 7.5,150 mM NaCl, 1 mM EGTA, 1 mM Na 2EDTA, 1% sodium deoxycholate, 1% NP-40, 1 mM beta-glycerophosphate,1m MN a 3VO4, 2.5 mM sodium pyrophosphate, 1 Œºg/mL leu- peptin, and 1 mM phenylmethanesulfonyl Ô¨Çuoride for the assessment of HDAC3 and DNMT1. All brain homogenateswere subjected to a 12,000 gcentrifugation at 4 ¬∞Cf o r1 0 minutes.A volume of 80 Œºg of sample was incubated with loading bu Ô¨Äer Tris-Glycine SDS-PAGE (Bio-Rad, USA) for 10 minutes at 95¬∞C.Then, 20 ŒºL of the mixture was loaded on SDS-polyacrylamide gel and separated it by sodium dode-cyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).Following the electrophoresis process, protein bands weretransferred from the gel to nitrocellulose membranes, and theywere washed with 0.05% TBS-T.
After the washing process,the membranes were incubated in a blocking bu Ô¨Äer containing 5% skim milk and 0.1% TBS-T at 25 ¬∞Cf o r1h o u r .A tt h ee n d of an incubation period, they were incubated with one of thefollowing primary antibodies: IL-6 (dilution 1 : 1000), TNF- Œ± (dilution 1 : 1000), DNMT-1 (dilution 1 : 1000), HDAC-3 Male wistar rats (weighing 180-220 g, age 8-10 weeks) High-carbohydrate high-fat (HCHF) Normal dietVehiclePositive control (i) Neurological deficit score, brain infarction volume and brain water content (ii) Neuron density in cerebral cortex(iii) Biological assessments: oxidative stress alteration in cerebral cortex(iv) The expression of inflammatory markers : IL-6 and TNF-ùõº (v) The expression of DNMT1 and HDAC33.Rt.MCAO4.VitaminC (250 mg/kg BW)5.Piracetam (250 mg/kg BW)6. GCJ (100 mg/kg BW)7.GCJ (200 mg/kg BW)8.
GCJ (300 mg/kg BW) Terminated2.Sham operation1.Na√Øve control group % Change of BW > 40% AIP > control groupFasting plasma glucose > 100 mg/dlSystolic blood pressure > 130 or Diastolic blood pressure > 85 mmHgRight middle cerebral artery occlusion (MCAO) group by ischemic reperfusion technique (60-90 min) (n = 6) Oral route 21 days Oral route 21 daysHCHF 16 weeks Neurological deficit score, every 7 daysRight middle cerebral artery (MCAO) group by ischemia reperfusion injury technique (60-90 minutes) GCJ (a) Terminate dRight middle cerebral artery occlusion 90 min Day 21 Day 7 Day 14 Neurological deficit score, every 7 daysGCJ100, GCJ200, GCJ300 (mg/kg BW), oral route 21 Days Induced MetS with HCHF 16 weeksGCJ100, GCJ200, GCJ300 (mg/kg BW), oral route (b) Figure 1: Schematic diagram showing all interventions and assessments used in this study. (a) Diagram of the experimental protocol showing all interventions and assessments.
(b) Time schedules of treatments, the occlusion of middle cerebral artery, and the neurological de Ô¨Åcit assessment.4 BioMed Research International (dilution 1 : 1000), and Œ≤-actin (dilution 1 : 2000) (Cell Signal- ing Technology, USA) for 2 hours at 25¬∞C. All membranes were then washed with 0.05% T-PBS for 30 minutes.Further incubation with secondary enzyme-linked antibody (anti-rab- bit IgG, HRP-linked antibody obtained from Cell SignalingTechnology, USA; dilution 1 : 2000) was carried out toenhance signal transduction.The protein band densities weredetected using ECL detection systems and the LAS-4000 lumi-nescent image analyzer (GE Healthcare).ImageJ software sys-tem was used for the analysis of the band densities.The banddensity control normal group ‚Äôs numeric variables were expressed as relative density [25].2.10.Statistical Analysis.Data obtained from this study were expressed as mean ¬± SEM and statistically analyzed using SPSS software version 25.0.
The statistical di Ô¨Äerence between the groups was obtained using a one-way analysis of variance (ANOVA) whereas the data analyzed repetitively were per-formed with repeated measurement ANOVA, followed by a Tukey post hoc test. The pvalues below 0.05 were considered as signi Ô¨Åcant changes between the test groups.3.Results 3.1.The Modi Ô¨Åed Neurological Severity Score (mNSS), Brain Infarction Volume, and Brain Water Content.Figure 2 shows the motor de Ô¨Åcit assessed by using mNSS.Our results showed that HCHF diet treated rats which received sham operation showed no signi Ô¨Åcant neurological de Ô¨Åcit whereas HCHF diet treated rats which received MCAO showed the signi Ô¨Åcant increase in mNSS when compared to the rats which receivednormal diet and vehicle treatments throughout the studyperiod ( pvalue <0.001, all).
These data suggested that HCHFplus sham operation and vehicle treatment produced no in Ô¨Çu- ence on mNSS and the alteration in mNSS observed in HCHF+MCAO+vehicle appeared to occur as the result of MCAO. When compared between HCHF diet treated rats subjected to sham operation and HCHF diet treated rats which sub-jected to MCAO, our data showed that MCAO signi Ô¨Åcantly increased mNSS in HCHF diet treated rats at 7, 14, and 21days after MCAO ( pvalue <0.001, all).These data pointed out that MCAO played an essential role on the elevation ofmNSS.The signi Ô¨Åcant elevation in mNSS induced by MCAO was mitigated by vitamin C, piracetam, and GCJ at the dosesof 100, 200, and 300 mg/kg BW throughout the study period(pvalue <0.001, all) as shown in Figure 2.Owing to the same pattern of changes in mNSS induced by the substances men-tioned earlier, the similar underlying mechanisms of the tested substances had been considered.
The e Ô¨Äect of various treatments in this study on brain infarction volume was also monitored, and results are shown in Figure 3. It was found that no brain infarction volume wasobserved in rats fed with normal diet and received vehicle(ND+vehicle) and in rats fed with HCHF diet and receivedsham operation plus vehicle treatment.These data suggestedthat HCHF plus sham operation and vehicle treatment failedto produce brain infarction.MCAO signi Ô¨Åcantly increased brain infarction volume in the cerebral cortex, striatum,and hippocampus when compared to the ND+vehicle group(pvalue <0.001).The comparison of brain infarction vol- ume between HCHF+MCAO+vehicle treated rats andHCHF+sham+vehicle treated also showed the same pattern(pvalue <0.001, all).Therefore, a brain infarction volume observed in this group occurred because of MCAO.
Alltreatments in this study including the treatments with vita-min C, piracetam, and all doses of GCJ used in this study 02468101214 Day 7 Day 14 Day 21Neurological deficit scoreAAA AAA AAA BBB BBB BBB‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ND + Vehicle HCHF + MCAO + GCJ200 HCHF + MCAO + VehicleHCHF + MCAO + Piracetam HCHF + Sham + Vehicle HCHF + MCAO + GCJ100 HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ300 Figure 2: EÔ¨Äect of the polyherbal recipe containing ginger, Chinese date, and wood ear mushroom (GCJ) at the doses of 100, 200, and 300 mg/kg BW on the neurological de Ô¨Åcit score assessed using the method of neurological severity scores (mNSS).
Data were presented asmean ¬± SEM (N=6/group).AAASigniÔ¨Åcant di Ô¨Äerence from the na√Øve control group (ND+vehicle) at pvalue <0.001;BBBsigniÔ¨Å cant diÔ¨Äerence from HCHF diet treated rats plus sham operation group (HCHF+sham+vehicle);‚àó‚àó‚àósigniÔ¨Å cant di Ô¨Äerence from HCHF diet treated rats plus MCAO and vehicle (HCHF+MCAO+vehicle).5 BioMed Research International showed the signi Ô¨Åcant mitigation in brain infarction volume in all brain regions mentioned earlier of HCHF diet treated rats subjected to MCAO ( pvalue <0.001, all). These data also pointed out that the mitigation e Ô¨Äect on brain infarction of the GCJ mentioned earlier might occur via the reductionof oxidative stress and the improvement of cerebral bloodÔ¨Çow similar to the e Ô¨Äects of vitamin C and piracetam.The eÔ¨Äect of various interventions on brain water content is shown in Figure 4.The current data showed no signi Ô¨Åcant diÔ¨Äerence in the contralateral brain water content.
In addition, HCHF diet treated rats which received sham operation andvehicle also failed to show the signi Ô¨Åcant change in the ipsilat- eral brain water content. These data indicated that HCHF, sham operation, and vehicle exerted no signi Ô¨Åcant in Ô¨Çuence on the brain water content.When compared to ND+vehicle treated rats, MCAO signi Ô¨Åcantly enhanced the ipsilateral brain water content ( pvalue <0.01) but no signi Ô¨Åcant di Ô¨Äer- ence was observed when compared to HCHF+sham+vehicle.Therefore, HCHF+sham+vehicle might also produce slightchange on brain edema although the change was not signi Ô¨Å- cant.This might be associated with the injury induced by anoperation.Piracetam and GCJ at the doses of 100, 200, and 300 mg/kg BW signi Ô¨Åcantly decreased the elevation of the ipsi- lateral brain water content in HCHF rats which received MCAO ( pvalue <0.05, 0.01, 0.01, and 0.01, respectively; com- pared to HCHF+MCAO+vehicle).
These changes suggestedthat the improvement in brain edema was not principallyattributed to an oxidative stress but might be principally asso-ciated with the alteration in the blood Ô¨Çow dynamic like the action of piracetam. 3.2.Cortical Neuron Density.The e Ô¨Äect of various interven- tions on cortical neuron density is shown in Figure 5.When compared to the ND+vehicle group, HCHF plus sham opera-tion and vehicle treated rats showed a slight reduction in neu-ron density in the cerebral cortex but no signi Ô¨Åcance was observed.MCAO signi Ô¨Åcantly decreased the cortical neuron density in HCHF plus vehicle treated rats ( pvalue <0.001, compared to the ND+vehicle group; pvalue <0.01, compared to the HCHF+sham+vehicle group).
The reduction of neurondensity in the cortical area induced by MCAO was attenuatedby piracetam and GCJ at the doses of 100, 200, and 300 mg/kg HCHF + MCAO + Vitamin CHCHF + MCAO + GCJ100HCHF + MCAO + VehicleND + Vehicle HCHF + Sham + VehicleHCHF + MCAO + PiracetamHCHF + MCAO + GCJ200HCHF + MCAO + GCJ30010 mm 10 mm 10 mm 10 mm 10 mm 10 mm 10 mm 10 mm (a) 05101520253035 Cortex Striatum HippocampusBrain infarction volume (mm3)AAA BBB BBB BBBAAA AAA‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé‚Åé ND + Vehicle HCHF + MCAO + GCJ200 HCHF + MCAO + VehicleHCHF + MCAO + Piracetam HCHF + Sham + Vehicle HCHF + MCAO + GCJ100 HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ300 (b) Figure 3: EÔ¨Äect of the polyherbal recipe containing ginger, Chinese date, and wood ear mushroom (GCJ) at the doses of 100, 200, and 300 mg/kg BW on brain infarction volume. (a) Representative TTC staining image of all treatment groups.
(b) Brain infarction area in the cerebral cortex, striatum, and hippocampus of all treatment groups. Data were expressed as mean ¬± SEM (N=6/group).AAApvalue <0.001 vs.ND+vehicle;BBBpvalue <0.001 vs.HCHF+sham+vehicle;‚àó‚àó‚àópvalue <0.001 vs.HCHF+MCAO+vehicle.6 BioMed Research International BW (pvalue <0.01, 0.001, 0.001, and 0.01, respectively; com- pared to HCHF+MCAO+vehicle treated rats).Therefore, GCJ at all dosage range used in this study might exert the neuro-protective e Ô¨Äect via an antioxidant activity same as piracetam.3.3.Oxidative Stress Changes.
The eÔ¨Äect of GCJ on the alteration of oxidative stress status of the cerebral cortex, a brain regionwhich showed the optimum changes induced by MCAO, wasmonitored via the alterations of the level of a lipid peroxida-tion product or MDA level and the alterations of main antiox-idant enzymes in the brain including SOD, CAT, and GPx.Table 1 shows that HCHF+sham+vehicle treated rats failedto show the signi Ô¨Åcant changes of all parameters mentioned above in the cerebral cortex. These data suggested that MetS rats induced by HCHF diet subjected to sham operation and vehicle treatment did not produce any signi Ô¨Åcant e Ô¨Äect on oxi- dative stress status.HCHF+MCAO+vehicle treated rats signif-icantly decreased the activities of SOD ( pvalue <0.001, compared to ND+vehicle; pvalue <0.001, compared to HCHF+sham+vehicle), CAT ( pvalue <0.001, compared to ND+vehicle; pvalue <0.001, compared to HCHF+sham +vehicle), and GPx ( pvalue <0.01, compared to ND+vehicle).
However, the level of MDA in this brain region of HCHF+MCAO+vehicle treated rats was increased ( pvalue <0.01, compared to ND+vehicle; pvalue <0.01, compared to HCHF+sham+vehicle). Vitamin C and GCJ at all doses usedin this study signi Ô¨Åcantly mitigated the changes of MDA ( p value <0.05, 0.01, 0.01, and 0.1, respectively; compared to HCHF+MCAO+vehicle), SOD ( pvalue <0.001, all; com-pared to HCHF+MCAO+vehicle), and CAT ( pvalue <0.01, 0.01, 0.001, and 0.01, respectively; compared to HCHF+MCAO+vehicle).The signi Ô¨Åcant increase in GPx was also observed in HCHF and MCAO treated rats which receivedvitamin C and GCJ at the doses of 200 and 300 mg/kg BW(pvalue <0.05, all; compared to HCHF+MCAO+vehicle).Piracetam treatment could enhance only CAT activity inHCHF+MCAO treated rats ( pvalue <0.01, compared to HCHF+MCAO+vehicle).3.4.In Ô¨Çammation and Epigenetic Mechanism.
The e Ô¨Äects of GCJ on the expressions of in Ô¨Çammatory cytokines such as IL-6 and TNF- Œ±and epigenetic mechanism via the modi Ô¨Åca- tion of HDAC3 and DNMT1 were also determined, and results are shown in Figure 6. Figures 6(a) ‚Äì6(c) revealed that no signi Ô¨Åcant changes in the cortical expressions of both IL- 6 and TNF- Œ±were observed in HCHF+sham+vehicle treated rats.Therefore, sham operation and vehicle treatment pro- duced no e Ô¨Äects on both HDAC3 and DNMT1 in MetS rats induced by HCHF.MCAO signi Ô¨Åcantly increased the corti- cal expressions of IL-6 and TNF- Œ±(pvalue <0.01 and 0.001, respectively; compared to ND+vehicle) in MetS rats inducedby HCHF diet.
Interestingly, GCJ at the doses of 100, 200,and 300 mg/kg BW signi Ô¨Åcantly decreased the expressions of IL-6 ( pvalue <0.05, 0.05, and 0.001, respectively; com- pared to HCHF+MCAO+vehicle) and TNF- Œ±(pvalue < 0.001, all; compared to HCHF+MCAO+vehicle) while vita-min C failed to show the positive modulation e Ô¨Äect on both IL-6 and TNF- Œ±and piracetam signi Ô¨Åcantly decreased only 020406080100120 Left side Right sideBrain water content (%)AA ‚Åé‚Åé ‚Åé‚Åé ‚Åé‚Åé ‚Åé ND + Vehicle HCHF + MCAO + GCJ200 HCHF + MCAO + VehicleHCHF + MCAO + Piracetam HCHF + Sham + Vehicle HCHF + MCAO + GCJ100 HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ300 Figure 4: EÔ¨Äect of the polyherbal recipe containing ginger, Chinese date, and wood ear mushroom (GCJ) at the doses of 100, 200, and 300 mg/kg BW on both contralateral (left) and ipsilateral (right) brain water content.
Data were as expressed as mean ¬± SEM (N=6 /group).AApvalue <0.01, compared to ND+vehicle;‚àó,‚àó‚àópvalue <0.05 and 0.001, respectively, compared to HCHF+MCAO+vehicle.7 BioMed Research International ND + VehicleHCHF + Sham + VehicleHCHF + MCAO + VehicleHCHF + MCAO + Vitamin C HCHF + MCAO + PiracetamHCHF + MCAO + GCJ100HCHF + MCAO + GCJ200HCHF + MCAO + GCJ300 50 ùúám 50 ùúám 50 ùúám 50 ùúám50 ùúám 50 ùúám 50 ùúám 50 ùúám (a) 0102030405060 CortexCortical neuron density (Neuron/225 ùúám2)AAA BB ‚Åé‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ND + Vehicle HCHF + MCAO + GCJ200 HCHF + MCAO + VehicleHCHF + MCAO + Piracetam HCHF + Sham + Vehicle HCHF + MCAO + GCJ100 HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ300 (b) Figure 5: EÔ¨Äect of the polyherbal recipe containing ginger, Chinese date, and wood ear mushroom (GCJ) at the doses of 100, 200, and 300 mg/kg BW on cortical neuron density. (a) Light microscope of coronal sections in the cerebral cortex was stained with cresyl violet at 40x magni Ô¨Åcation.
(b) Density of survival neurons in the cerebral cortex. Data were expressed as mean ¬± SEM (N=6/group).AAAp value <0.001, compared to ND+vehicle;BBpvalue <0.01, compared to HCHF+sham+vehicle;‚àó‚àó,‚àó‚àó‚àópvalue <0.01 and 0.001, respectively, compared to HCHF+MCAO+vehicle.Table 1: EÔ¨Äect of the polyherbal recipe containing ginger, Chinese date, and wood ear mushroom (GCJ) at the doses of 100, 200, and 300 mg/kg BW on oxidative stress parameters including malondialdehyde (MDA) level and the activities of superoxide dismutase (SOD),catalase (CAT), and glutathione peroxidase (GPx) in the cerebral cortex ( N=6/group).
Treatment groupMDA level (ng/mg protein)SOD activity (units/mg ¬∑protein)CAT activity (units/mg ¬∑protein)GPx activity (unit/mg ¬∑protein) ND + vehicle 0:29 ¬± 0: 04 15:23 ¬± 0: 59 38:29 ¬± 2: 16 4:59 ¬± 0: 41 HCHF+sham+vehicle 0:30 ¬± 0: 06 15:41 ¬± 0: 45 34:67 ¬± 4: 47 3:41 ¬± 0: 21 HCHF+MCAO+vehicle 0:68 ¬± 0: 06 aa,bb6:76 ¬± 0: 16aaa,bbb15:33 ¬± 1: 52aaa,bbb2:45 ¬± 0: 32aa HCHF+MCAO+vitamin C 0:37 ¬± 0: 04‚àó14:74 ¬± 0: 28‚àó‚àó‚àó31:88 ¬± 2: 57‚àó‚àó4:27 ¬± 0: 38‚àó HCHF+MCAO+piracetam 0:54 ¬± 0: 11 9:02 ¬± 0: 06 30:91 ¬± 4: 64‚àó‚àó4:02 ¬± 0: 22 HCHF+MCAO+GCJ100 0:36 ¬± 0: 04‚àó‚àó12:91 ¬± 0: 49‚àó‚àó‚àó31:61 ¬± 1: 56‚àó‚àó4:04 ¬± 0: 38 HCHF+MCAO+GCJ200 0:35 ¬± 0: 02‚àó‚àó13:03 ¬± 0: 35‚àó‚àó‚àó34:21 ¬± 1: 63‚àó‚àó‚àó4:34 ¬± 0: 39‚àó HCHF+MCAO+GCJ300 0:35 ¬± 0: 02‚àó‚àó14:72 ¬± 1: 60‚àó‚àó‚àó31:47 ¬± 0: 53‚àó‚àó4:16 ¬± 0: 27‚àó Data were presented as mean ¬± SEM .aa,aaapvalue <0.01 and 0.001, respectively, compared to ND+vehicle;bb,bbbpvalue <0.01 and 0.001, respectively, compared to HCHF+sham+vehicle;‚àó,‚àó‚àó,‚àó‚àó‚àópvalue <0.05, 0.01, and 0.001, respectively, compared to HCHF+MCAO+vehicle.8 BioMed Research International IL-6 TNF-ùõº DNMT1 HDAC3 ùõΩ-actin(23 kDa) (25 kDa) (183 kDa) (50 kDa) (43 kDa) ND + Vehicle HCHF + MCAO + GCJ200HCHF + MCAO + Vehicle HCHF + MCAO + PiracetamHCHF + Sham + Vehicle HCHF + MCAO + GCJ100HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ300 (a) 00.20.40.60.811.21.41.61.8IL-6 (relative density)AA ‚Åé‚Åé‚Åé‚Åé‚Åé ND + Vehicle HCHF + MCAO + GCJ200HCHF + MCAO + Piracetam HCHF + MCAO + GCJ300HCHF + MCAO + VehicleHCHF + Sham + Vehicle HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ100 (b)ND + Vehicle HCHF + MCAO + GCJ200HCHF + MCAO + Piracetam HCHF + MCAO + GCJ300HCHF + MCAO + VehicleHCHF + Sham + Vehicle HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ100 ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé‚Åé‚Åé 00.511.522.53TNF-ùõº (relative density)AAA (c) Figure 6: Continued.9 BioMed Research International TNF- Œ±expression ( pvalue <0.001, compared to HCHF +MCAO+vehicle).
Our data in Figures 6(a), 6(d), and 6(e) clearly demon- strated that HCHF+sham+vehicle treated rats failed to show the signi Ô¨Åcant changes in both DNMT1 and HDAC3. These data suggested that sham operation did not modify the expres-sions of both parameters in MetS rats induced by HCHF diet.HCHF+MCAO+vehicle produced the signi Ô¨Åcant elevation in the cortical expressions of the aforementioned parameters ( p value <0.05, all, compared to HCHF+MCAO+vehicle and p value <0.05, all, compared to HCHF+MCAO+vehicle).Therefore, the changes in DNMT1 and HDAC3 expressionin MetS rats induced by HCHF diet might occur as the resultof MCAO.The elevation of DNMT1 expression in the cerebral cortex of HCHF+MCAO+vehicle treated rats was attenuated by vitamin C, piracetam, and all doses of GCJ used in thisstudy ( pvalue <0.01, 0.05, 0.05, 0.01, and 0.001, respectively; compared to HCHF+MCAO+vehicle).
In addition, all inter-ventions mentioned earlier also mitigated the elevation ofHDAC3 in the cerebral cortex of HCHF+MCAO+vehicletreated rats ( pvalue <0.01, 0.01, 0.05, 0.05, and 0.001, respec- tively; compared to HCHF+MCAO+vehicle). 4.Discussion This is the Ô¨Årst report to demonstrate the neuroprotection against cerebral ischemia with metabolic syndrome of thereputed polyherbal recipe widely used in the Thai-Chinesedescendants for a long time.Interestingly, it can exert theeÔ¨Äect to modulate epigenetic mechanism via the suppression of DNMT1 and HDAC3 expression in the cerebral cortex.The changes are observed accompanied with the reductionof MDA, a lipid peroxidation marker, and in Ô¨Çammatory cytokines such as IL-6 and TNF- Œ±, the elevation of antioxi- dant enzymes such as SOD, CAT, and GPx, and the reduc-tion of brain infarction volume, neurodegeneration, brainedema, and neurological de Ô¨Åcit.
In this study, a transient ischemic rat has been used as an animal model owing to its reputation as the best model forstudying the survival and the functional recovery of ischemicstroke [29]. It has been demonstrated that a transient occlu-sion of a middle cerebral artery induces oxidative stress and neuroin Ô¨Çammation [30].The substances possessing the sup- pression e Ô¨Äect on oxidative stress and neuroin Ô¨Çammation such as polyphenol can improve brain damage and brain dys- function in an ischemic stroke model [31, 32].These pieces ofinformation correspond with our results which demonstratedthat all doses of GCJ, a polyphenol-enriched polyherbal recipecontaining ginger, Chinese date, and wood ear mushroom,also improve both oxidative stress status and in Ô¨Çammation leading to an improvement of neurological de Ô¨Åcit.Recently, the role of epigenetic mechanism in the regula- tion of gene transcription in stroke has been clearly revealed [26, 33].
The current data showed the elevation of DNMT1 and HDAC3 in cerebral ischemia corresponding with thechanges in the previous studies [34‚Äì39]. These changes areND + Vehicle HCHF + MCAO + GCJ200HCHF + MCAO + Piracetam HCHF + MCAO + GCJ300HCHF + MCAO + VehicleHCHF + Sham + Vehicle HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ100 00.20.40.60.811.21.4DNMT1 (relative density)‚Åé‚Åé‚Åé ‚Åé‚Åé ‚Åé‚Åé‚Åé‚ÅéA B (d)ND + Vehicle HCHF + MCAO + GCJ200HCHF + MCAO + Piracetam HCHF + MCAO + GCJ300HCHF + MCAO + VehicleHCHF + Sham + Vehicle HCHF + MCAO + Vitamin C HCHF + MCAO + GCJ100 00.20.40.60.811.21.41.6HDAC3 (relative density)A B‚Åé‚Åé ‚Åé‚Åé ‚Åé‚Åé‚Åé ‚Åé (e) Figure 6: EÔ¨Äects of the polyherbal recipe containing ginger, Chinese date, and wood ear mushroom (GCJ) at the doses of 100, 200, and 300 mg/kg BW on the cortical expressions of interleukin-6 (IL-6) and tumor necrosis factor-Œ± (TNF-Œ± ).(a) Representative bands of IL-6, TNF- Œ±, DNMT1, and HDAC3 from the cerebral cortex of various treatment groups.
Statistical data from the western blot analysis for the cortical expression of (b) IL-6, (c) TNF- Œ±, (d) DNMT1, and (e) HDAC3. Data were expressed as mean ¬± SEM (N=6/group).A,AA,AAApvalue <0.05, 0.01, and 0.001, respectively, compared to ND+vehicle;Bpvalue <0.05, compared to HCHF+sham+vehicle; ‚àó,‚àó‚àó,‚àó‚àó‚àópvalue <0.05, 0.01, and 0.001, respectively, compared to HCHF+MCAO+vehicle.10 BioMed Research International associated with brain edema [40], neuronal loss, neuronal deÔ¨Åcit, and neuronal recovery in cerebral ischemia [41].In addition, an epigenetic mechanism also plays an essentialrole on the regulation of in Ô¨Çammation [42‚Äì 44].Moreover, epigenetic mechanism process of the histone modi Ô¨Åcation via HDAC3 also regulates oxidative stress balance.The sup-pression of HDAC3 can improve oxidative stress imbalanceand brain damage in cerebral ischemia [25, 33].
Theimprovement in oxidative stress imbalance and in Ô¨Çamma- tion in turn give rise to the decrease in neurodegenerationand brain infarction induced by MCAO and Ô¨Ånally improve neurological de Ô¨Åcit. In addition, brain damage following ischemic stroke often disrupts the blood-brain barrier givingrise to an increase in paracellular permeability resulting inthe extravasation of blood components into the brain andÔ¨Ånally induces cerebral vasogenic edema [41].Therefore, the increase in brain water content which indicated brain edemaobserved in this study might occur as the result of a cerebralvasogenic edema induced by brain damage and blood-brainbarrier disruption.The reduction of brain edema induced byGCJ may be associated with the reduction in brain damagewhich in turn decreases blood-brain barrier disruption.Our data clearly revealed that MCAO produces a signif- icant increase in cortical expression of DNMT1 and HDAC3in HCHF+vehicle treated rats.
This Ô¨Ånding is in agreement with the previous results obtained from many studies[42‚Äì46]. Taken all data together, we suggest that GCJ pro- tects against brain damage and brain dysfunction in animalmodel ischemia stroke with metabolic syndrome conditionvia the suppression of DNMT1 and HDAC3 expressions inthe cerebral cortex giving rise to the decrease in in Ô¨Çamma- tion [42] via the reduction of IL-6 and TNF- Œ±leading to an improvement of brain infarction area and brain edematogether with the neurological de Ô¨Åcit.In addition, the sup- pression of HDAC3 also suppresses oxidative stress whichin turn decreases brain infarction area, brain edema, andneurological de Ô¨Åcit.Due to the very high concentration ofa polyphenol such as gingerol in GCJ and the neuroprotec-tive eÔ¨Äect against stroke of ginger [47], we suggest that the possible active ingredient may partly involve gingerol pre-sented in GCJ.No dose-dependent e Ô¨Äect of GCJ is observed.
The possible explanation may be due to the masking e Ô¨Äect of other ingredients and the nonlinear relationship between theobserved parameters and the concentrations of GCJ. 5.Conclusion Since stroke produces a great socioeconomic burden and thecurrent therapeutic strategy is still limited, it is very essentialto prevent it [7].This study has been focused on the noninva-sive strategy for preventing the ischemic stroke with metabolicsyndrome which is more severe than ischemic stroke withoutmetabolic syndrome.This study is the Ô¨Årst scienti Ô¨Åce v i d e n c e to prove that the reputed polyherbal recipe (GCJ) can improvebrain damage and brain dysfunction induced by ischemicstroke with metabolic syndrome.
Moreover, the novelty isthe scienti Ô¨Åc evidence which clearly demonstrates the nutrige- nomic e Ô¨Äect of GCJ via the modulation e Ô¨Äect on an epigenetic mechanism by suppressing the expression of DNMT1 and HDAC3 in the cerebral cortex and gives rise to the reduction of inÔ¨Çammation and oxidative stress resulting in an increase of cortical neuron density and the reduction in brain infarc-tion, brain edema, and neurological de Ô¨Åcit as shown in Figure 7. Therefore, GCJ may serve as the potential candidatefood supplement for stroke protection.However, a clinicaltrial study to con Ô¨Årm this bene Ô¨Åt is essential.
Abbreviations BW: Body weight CAT: Catalase DNMT1: DNA methyltransferase 1DTT: DithiothreitolEDTA: Ethylenediaminetetraacetic acid Oxidative stress MDA SODCATGPxInflammation IL-6 TNF-ùõºEpigenetic mechanism DNA-methyltransferase-1 Histone deacetylase3Ischemic stroke MCAO R/I Brain damageGCJ Brain edema Figure 7: Schematic diagram of the possible underlying mechanism for the neuroprotective eÔ¨Ä ect of GCJ in the animal model of cerebral ischemia in metabolic syndrome condition.11 BioMed Research International GCJ: The polyherbal recipe containing the combined extract of ginger, Chinese date, and Jew ‚Äôs ear or wood ear mushroom GPx: Glutathione peroxidase HAT: Histone acetyltransferaseHCHF: High-carbohydrate high-fat dietHDAC3: Histone deacetylase 3I/R: Ischemic reperfusion injuryIL-6: Interleukin-6 MCAO: Middle cerebral artery occlusion MDA: MalondialdehydeMetS: Metabolic syndromemNSS: Modi Ô¨Åed neurological severity score systems ND: Normal dietSEM: Standard error of the meanSOD: Superoxide dismutaseTNF- Œ±: Tumor necrosis factor-alpha TTC: 2,3,5-Triphenyl tetrazolium chloride.
Data Availability The data used to support the Ô¨Åndings of this study are avail- able from the corresponding author upon request. Ethical Approval The animal study was reviewed and approved by the Institu-tional Animal Ethics Committee of Khon Kaen University,Khon Kaen, Thailand (record no.IACUC-KKU 42/63).Conflicts of Interest The authors declare that the research was conducted in theabsence of any commercial or Ô¨Ånancial relationships that could be construed as a potential conÔ¨Ç ict of interest.Authors ‚ÄôContributions JW, WP, and TN participated in research design.JW andTN were responsible for methodology.JW and TN wereresponsible for formal analysis.TN conducted experiments.JW, WP, and TN contributed in writing original draft prep-aration.JW was responsible for review and editing.JW wasresponsible for supervision.JW was responsible for projectadministration.JW was responsible for funding acquisition.
Acknowledgments The authors would like to express sincere gratitude to theThailand Science Research and Innovation (TSRI) throughthe Research and Researchers for Industries (RRI) project(research no. PHD59I0036), the Agricultural ResearchDevelopment Agency (ARDA), and the Integrative Comple-mentary Alternative Medicine Research and Development Center in the Research Institute for Human High Perfor- mance and Health Promotion, Khon Kaen University, KhonKaen, Thailand, for their supports.Supplementary Materials Supplementary materials about dataset of the original west-ern blot carried out in this study are attached as supplemen-tary material.(Supplementary Materials) References [1] A.T.Khafagy, N.A.Hamdy, E.M.Hassan et al., ‚ÄúAssociation between metabolic syndrome and atherothrombotic stroke: a clinical study in tertiary care hospital, Minia, Egypt, ‚ÄùThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery , vol.55, no.51, pp.51‚Äì55, 2019.[2] X.Zhang, Z.Sun, C.
Ding et al., ‚ÄúMetabolic syndrome augments the risk of early neurological deterioration in acute ischemicstroke patients independent of in Ô¨Çammatory mediators: a hospital-based prospective study, ‚ÄùOxidative Medicine and Cel- lular Longevity , vol. 2016, Article ID 8346301, 6 pages, 2016.[3] N.Obadia, M.A.Lessa, A.Daliry et al., ‚ÄúCerebral microvascu- lar dysfunction in metabolic syndrome is exacerbated by ische-mia‚Äìreperfusion injury, ‚ÄùBMC Neuroscience , vol.18, pp.1‚Äì10, 2017.[4] J.Maiuolo, M.Gliozzi, V.Musolino et al., ‚ÄúFrom metabolic syndrome to neurological diseases: role of autophagy, ‚ÄùFron- tiers in Cell and Developmental Biology , vol.9, article 651021, pp.619‚Äì635, 2021.[5] M.G.Saklayen, ‚ÄúThe global epidemic of the metabolic syn- drome, ‚ÄùCurrent Hypertension Reports , vol.20, no.2, pp.1‚Äì 8, 2018.[6] Z.Chen, M.Su, Z.Li et al., ‚ÄúMetabolic syndrome predicts poor outcome in acute ischemic stroke patients after endovascularthrombectomy, ‚ÄùNeuropsychiatric Disease and Treatment , vol.
2020, no. 16, pp.2045 ‚Äì2052, 2020.[7] H.Amani, H.E.Mostafavi, M.R.Alebouyeh et al., ‚ÄúWould colloidal gold nanocarriers present an eÔ¨Ä ective diagnosis or treatment for ischemic stroke?, ‚ÄùInternational Journal of Nanomedicine , vol.2019, no.14, pp.8013 ‚Äì8031, 2019.[8] S.Parasuraman, G.S.Thing, and S.A.Dhanaraj, ‚ÄúPolyherbal formulation: concept of Ayurveda, ‚ÄùPharmacognosy Reviews , vol.8, no.16, pp.73 ‚Äì80, 2014.[9] S.K.Panchal and L.Brown, ‚ÄúRodent models for metabolic syndrome research, ‚ÄùJournal of Biomedicine and Biotechnol- ogy, vol.2011, Article ID 351982, 14 pages, 2011.[10] S.K.Panchal, H.Poudyal, A.Iyer et al., ‚ÄúHigh-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascularremodeling in rats: erratum,‚Äù Cardiovascular Pharmacology , vol.57, no.5, pp.610‚Äì624, 2011.[11] E.L.Novelli, Y.S.Diniz, C.M.Galhardi et al., ‚ÄúAnthropome- trical parameters and markers of obesity in rats, ‚ÄùLaboratory Animals , vol.41, no.1, pp.111 ‚Äì119, 2007.[12] A.C.Ghezzi, L.T.Cambri, J.D.
Botezelli, C. Ribeiro, R.A.Dalia, and M.A.de Mello, ‚ÄúMetabolic syndrome markers in Wistar rats of di Ô¨Äerent ages, ‚ÄùDiabetology & Metabolic Syn- drome , vol.4, no.1, p.7, 2012.[13] Y.Wang, Y.Cong, J.Li, X.Li, B.Li, and S.Qi, ‚ÄúComparison of invasive blood pressure measurements from the caudal ventralartery and the femoral artery in male adult SD and Wistarrats,‚ÄùPLoS One , vol.8, no.4, article e60625, 2013.[14] R.F.Keep, Y.Hua, and G.Xi, ‚ÄúBrain water content: a misun- derstood measurement?, ‚ÄùTranslational Stroke Research , vol.3, no.2, pp.263 ‚Äì265, 2012.12 BioMed Research International [15] A.Ali, F.A.Shah, A.Zeb et al., ‚ÄúNf-Œöb inhibitors attenuate MCAO induced neurodegeneration and oxidative stress‚Äî a reproÔ¨Åling approach,‚Äù Frontiers in molecular neuroscience , vol.13, no.33, p.14, 2020.[16] F.A.Shah, T.Li, L.T.
Al Kury et al., ‚ÄúPathological compari- sons of the hippocampal changes in the transient and perma- nent middle cerebral artery occlusion rat models, ‚ÄùFrontiers in Neurology , vol. 10, no.1178, p.1178, 2019.[17] J.Yu, J.Moon, J.Jang et al., ‚ÄúReliability of behavioral tests in the middle cerebral artery occlusion model of rat, ‚ÄùLaboratory Animals , vol.53, no.5, pp.478 ‚Äì490, 2019.[18] M.Bieber, J.Gronewold, A.C.Scharf et al., ‚ÄúValidity and reli- ability of neurological scores in mice exposed to middle cere-bral artery occlusion, ‚ÄùStroke , vol.50, no.10, pp.2875 ‚Äì2882, 2019.[19] S.S.Rewell, L.Churilov, T.K.Sidon et al., ‚ÄúEvolution of ische- mic damage and behavioural de Ô¨Åcit over 6 months after MCAo in the rat: selecting the optimal outcomes and statisticalpower for multi-centre preclinical trials, ‚ÄùPLoS One , vol.12, no.2, article e0171688, 2017.[20] F.A.Shah, G.Liu, L.T.
Al Kury et al., ‚ÄúMelatonin protects MCAO-induced neuronal loss via Nr2a mediated prosurvivalpathways, ‚ÄùFrontiers in Pharmacology, vol. 10, no.297, p.297, 2019.[21] F.A.Shah, A.Zeb, T.Ali et al., ‚ÄúIdenti Ô¨Åcation of proteins dif- ferentially expressed in the striatum by melatonin in a middlecerebral artery occlusion rat model-a proteomic and in silicoapproach, ‚ÄùFrontiers in Neurosciences , vol.12, p.888, 2018.[22] J.Wattanathorn, W.Ohnon, W.Thukhammee, S.Muchmapura, P.Wannanon, and T.Tong-Un, ‚ÄúCerebro- protective eÔ¨Ä ect against cerebral ischemia of the combined extract of Oryza sativa and Anethum graveolens in metabolic syndrome rats, ‚ÄùOxidative Medicine and Cellular Longevity , vol.2019, Article ID 9658267, 19 pages, 2019.[23] H.Ohkawa, N.Ohishi, and K.Yagi, ‚ÄúAssay for lipid peroxides in animal tissues by thiobarbituric acid reaction, ‚ÄùAnalytical Biochemistry , vol.95, no.2, pp.351 ‚Äì358, 1979.[24] Y.I.Sun, L.W.Oberley, and Y.
Li, ‚ÄúA simple method for clin- ical assay of superoxide dismutase, ‚ÄùClinical Chemistry , vol. 34, no.3, pp.497 ‚Äì 500, 1988.[25] N.Palachai, J.Wattanathorn, S.Muchimapura, and W.Tukham-mee, ‚ÄúAntimetabolic syndrome eÔ¨Ä ect of phyto- some containing the combined extracts of mulberry and ginger in an animal model of metabolic syndrome, ‚ÄùOxidative medi- cine and cellular longevity , vol.2019, Article ID 5972575, 19 pages, 2019.[26] A.B.Uzdensky and S.Demyanenko, ‚ÄúHistone acetylation and deacetylation in ischemic stroke, ‚ÄùNeural Regeneration Research , vol.16, no.8, pp.1529-1530, 2021.[27] J.Krupinski, C.Carrera, E.Mui√±o et al., ‚ÄúDNA methylation in stroke.Update of latest advances, ‚ÄùComputational and Struc- tural Biotechnology Journal , vol.16, pp.1‚Äì5, 2017.[28] N.Palachai, J.Wattanathorn, S.Muchimapura, and W.
Thukham-mee, ‚ÄúPhytosome loading the combined extract of mulberry fruit and ginger protects against cerebral ischemiain metabolic syndrome rats, ‚ÄùOxidative Medicine and Cellular Longevity , vol. 2020, Article ID 5305437, 15 pages, 2020.[29] J.M.Livingston, M.W.McDonald, T.Gagnon et al., ‚ÄúInÔ¨Çu- ence of metabolic syndrome on cerebral perfusion and cog-nition, ‚ÄùNeurobiology of Disease , vol.137, article 104756, 2020.[30] F.A.Shah, L.A.Kury, T.Li et al., ‚ÄúPolydatin attenuates neuro- nal loss via reducing neuroin Ô¨Çammation and oxidative stress in rat MCAO models,‚Äù Frontiers in Pharmacology , vol.10, p.663, 2019.[31] D.J.Park, F.A.Shah, and P.O.Koh, ‚ÄúQuercetin attenuates neuronal cells damage in a middle cerebral artery occlusionanimal model, ‚ÄùJournal of Veterinary Medical Science , vol.80, no.4, pp.676 ‚Äì683, 2018.[32] F.A.Shah, S.A.Gim, J.H.Sung, S.J.Jeon, M.O.Kim, and P.O.Koh, ‚ÄúIdenti Ô¨Åcation of proteins regulated by curcumin in cerebral ischemia, ‚ÄùJournal of Surgical Research , vol.
201, no. 1, pp.141 ‚Äì148, 2016.[33] M.Asada, H.Hayashi, K.Murakami et al., ‚ÄúInvestigating the relationship between neuronal cell death and early DNA methylation after ischemic injury, ‚ÄùFrontiers in Neuroscience , vol.12, article 581915, p.13, 2020.[34] M.Endres, G.Fan, A.Meisel, U.Dirnagl, and R.Jaenisch, ‚ÄúEÔ¨Äects of cerebral ischemia in mice lacking DNA methyl- transferase 1 in post-mitotic neurons, ‚ÄùCinical Neuroscience and Neuropathology , vol.12, no.17, pp.3763 ‚Äì3766, 2001.[35] M.Endres, A.Meisel, D.Biniszkiewicz et al., ‚ÄúDNA methyl- transferase contributes to delayed ischemic brain injury, ‚ÄùJour- nal of Neuroscience , vol.20, no.9, pp.3175 ‚Äì3181, 2000.[36] S.Sharifulina, V.Dzreyan, V.Guzenko, and S.Demyanenko, ‚ÄúHistone methyltransferases Suv39h1 and G9a and DNA methyltransferase DNMT1 in penumbra neurons and astro- cytes after photothrombotic stroke, ‚ÄùInternational Journal of Molecular Sciences , vol.22, no.22, article 12483, 2021.[37] E.B.Fessler, F.L.Chibane, Z.Wang, and D.M.
Chuang, ‚ÄúPotential roles of HDAC inhibitors in mitigating ischemia- induced brain damage and facilitating endogenous regenera-tion and recovery,‚Äù Current Pharmaceutical Design , vol. 19, no.28, pp.5105 ‚Äì5120, 2013.[38] X.Yang, Q.Wu, L.Zhang, and L.Feng, ‚ÄúInhibition of histone deacetylase 3 (HDAC3) mediates ischemic preconditioning and protects cortical neurons against ischemia in rats, ‚ÄùFron- tiers in Molecular Neuroscience , vol.9, no.131, p.14, 2016.[39] H.Zhao, G.Li, S.Zhang et al., ‚ÄúInhibition of histone deacetyl- ase 3 by Mir-494 alleviates neuronal loss and improves neuro- logical recovery in experimental stroke, ‚ÄùJournal of Cerebral Blood Flow & Metabolism , vol.39, no.12, pp.2392 ‚Äì2405, 2019.[40] H.Lu, C.Lin, V.Clendaniel et al., ‚ÄúHistone deacetylase 3 inhi- bition decreases cerebral edema and protects the blood-brainbarrier after stroke, ‚ÄùNeuology , vol.98, p.14, 2022.[41] B.Zhao, Q.Yuan, J.B.
Hou et al., ‚ÄúInhibition of HDAC3 ame- liorates cerebral ischemia reperfusion injury in diabetic micein vivo and in vitro, ‚ÄùJournal of Diabetes Research , vol. 2019, Article ID 8520856, 12 pages, 2019.[42] Y.Liao, J.Cheng, X.Kong et al., ‚ÄúHDAC3 inhibition amelio- rates ischemia/reperfusion-induced brain injury by regulatingthe microglial Cgas-sting pathway, ‚ÄùTheranostics , vol.10, no.21, pp.9644 ‚Äì9662, 2020.[43] G.Y.Ng, Y.A.Lim, C.G.Sobey, T.Dheen, D.Y.Fann, and T.V.Arumugam, ‚ÄúEpigenetic regulation of in Ô¨Çammation in stroke, ‚ÄùTherapeutic Advances in Neurological Disorders , vol.2018, article 1756286418771815, 30 pages, 2018.[44] Y.Xu, Q.Wang, J.Chen, Y.Ma, and X.Liu, ‚ÄúUpdating a strat- egy for histone deacetylases and its inhibitors in the potentialtreatment of cerebral ischemic stroke, ‚ÄùDisease Markers, vol.2020, Article ID 8820803, 8 pages, 2020.13 BioMed Research International [45] S.Chen, L.Shao, and L.
Ma, ‚ÄúCerebral edema formation after stroke: emphasis on blood ‚Äìbrain barrier and the lymphatic drainage system of the brain, ‚ÄùFrontiers in Cellular Neurosci- ence, vol. 15, pp.314 ‚Äì331, 2021.[46] J.Yu, Y.Qiu, J.Yang et al., ‚ÄúDNMT1-PPAR Œ≥pathway in mac- rophages regulates chronic in Ô¨Çammation and atherosclerosis development in mice,‚Äù Scienti Ô¨Åc Reports , vol.6, no.1, article 30053, 2016.[47] J.Wattanathorn, J.Jittiwat, T.Tongun, S.Muchimapura, and K.Ingkaninan, ‚ÄúZingiber o Ô¨Écinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat,‚ÄùEvidence-Based Complementary and Alternative Medi- cine, vol.2011, Article ID 429505, 8 pages, 2011.14 BioMed Research International
